| Bioactivity | PARP1-IN-29 is an orally active PARP-1 inhibitor with an IC50 value of 6.3 nM. PARP1-IN-29, after being labeled with [18F], can be used for positron emission tomography (PET) imaging, specifically targeting PARP-1 in tumors. PARP1-IN-29 is applicable in the fields of oncology and imaging research, particularly for detecting PARP-1 activity in cancer[1]. | ||||||||||||
| CAS | 1567375-93-2 | ||||||||||||
| Formula | C18H16FN3O2 | ||||||||||||
| Molar Mass | 325.34 | ||||||||||||
| Appearance | 固体 | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Zhou D, et al. Synthesis, [¹⁸F] radiolabeling, and evaluation of poly (ADP-ribose) polymerase-1 (PARP-1) inhibitors for in vivo imaging of PARP-1 using positron emission tomography. Bioorg Med Chem. 2014 Mar 1;22(5):1700-7. |
PARP1-IN-29
CAS: 1567375-93-2 F: C18H16FN3O2 W: 325.34
PARP1-IN-29 is an orally active PARP-1 inhibitor with an IC50 value of 6.3 nM. PARP1-IN-29, after being labeled with , c
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.